Ditropan XL Generic Ready For Launch Pending FDA Approval, J&J Citizen Petition
This article was originally published in The Pink Sheet Daily
Executive Summary
Final appellate court ruling triggers an “exclusive supply agreement” between J&J and Mylan.
You may also be interested in...
Mylan Undaunted By Other Duragesic Generics
Fentanyl patch competitors have yet to deliver the product dependably, says Mylan CEO.
FDA “First Generics” Policy Not Enough, Mylan CEO Says
Agency's ANDA review needs a top-to-bottom policy overhaul to end approval delays, Coury says.
Mylan Undaunted By Other Duragesic Generics
Fentanyl patch competitors have yet to deliver the product dependably, says Mylan CEO.